Skip to content

Effectiveness of the Integration of Traditional Chinese Medicine and Western Medicine (Integrative Medicine) in Treating Major Depressive Disorder: A Randomised Controlled Trial (RCT)

Effectiveness of the Integration of Traditional Chinese Medicine and Western Medicine (Integrative Medicine) in Treating Major Depressive Disorder: A Randomised Controlled Trial (RCT) - Effectiveness of the Integration of Traditional Chinese Medicine and Western Medicine (Integrative Medicine) in Treating Major Depressive Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059857
Enrollment
Unknown
Registered
2022-05-13
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

A:Western medicine (Sertraline)
B:Western medicine (Sertraline) and Non-invasive TCM(Herbal medicine and auricular acupressure)
C:Western medicine (Sertraline) and Comprehensive TCM (Herbal medicine, auricular acupressure, and acupuncture)

Sponsors

Wushan County Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with mild or moderate depression by the relevant attending physician in reference to the International Classification of Diseases (ICD-10 F-32) [38] are recommended to a psychiatrist. Psychiatrists will evaluate the referred patients using HAMD-24 scores and divide patients into: Mild depression (8 35). Each group is randomly divided into Group A, B, and C; 2. Age of subjects: 18-60 years old. 3. Meet the criteria for diagnosis of depression, Hamilton Depression Scale (HAMD) 24 rating: 8-35 points. 4. Consented.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with other severe organic diseases; 2. Terminally ill patients, including those with survival time less than 6 months, having severe organ function injury, unstable vital signs, and coma; 3. Concomitant other psychotic disorders and long-term consumption of psychotropic drug; 4. Acute suicidality; 5. Substance dependence; 6. Pregnant or lactating women, or fertile subjects who are not willing or unable to take effective contraceptive measures.

Design outcomes

Primary

MeasureTime frame
Hamilton rating scale for depression (24-items) (HAMD-24);Treatment Emergent Symptom Scale, TESS;

Secondary

MeasureTime frame
Family Burden Scale, FBS;36-Item Short Form Survey (SF-36);Beck Depression Inventory-II (BDI-II);Pittsburgh sleep quality index, PSQI;

Countries

China

Contacts

Public ContactHan Yaosong

Wushan County Hospital of Traditional Chinese Medicine

hanyaosong@outlook.com+86 15923866684

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026